Stock Comparison
TEVA vs VTRS
Teva Pharma Industries Ltd ADR and Viatris Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.67B
$19.02B
P/E (TTM)
24.8
—
Forward P/E
16.0
6.6
Price/Sales
2.2
1.3
Price/Book
4.7
1.3
EV/EBITDA
16.3
12.6
Dividend Yield
—
2.99%
Profitability
Net Margin
9.02%
-2.04%
Operating Margin
19.20%
6.78%
Return on Equity
21.60%
-1.96%
Return on Assets
6.38%
2.31%
Growth (YoY)
Revenue Growth
2.30%
8.10%
Earnings Growth
72.20%
-70.60%
Price & Risk
Beta
0.9
0.9
52-Week High
$37.35
$17.40
52-Week Low
$14.99
$8.30
Analyst Target
$40.90
$17.81
Compare TEVA and VTRS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.